Streetbeat News

Stock Prices

NTES

NetEase shares rose by 7.22% due to a monetary stimulus package from the People's Bank of China, which cut reserve requirement ratios and policy rates. This move is expected to benefit sectors like online gaming and e-commerce, where NetEase is a key player.

Portfolio Pulse from Henry Khederian

September 24, 2024 | 6:15 pm

SPY

Former President Donald Trump has expressed the opinion that the United States should withdraw its involvement in Ukraine. This statement could influence market sentiment, particularly in sectors related to defense and international relations.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 6:14 pm

BTCUSD

MNWUSD

The article discusses the rising food inflation in the U.S., with former President Trump blaming Democrats, while experts suggest blockchain as a potential solution. The Federal Reserve has lowered interest rates to prevent an economic slowdown. Trump has positioned himself as a Bitcoin-friendly candidate, recently making his first Bitcoin transaction.

Portfolio Pulse from Justin Roberti

September 24, 2024 | 6:11 pm

BIVI

LASE

LNW

MSS

SEEL

THO

WVE

U.S. stocks showed mixed performance with the Dow slightly down and NASDAQ and S&P 500 up. Thor Industries reported better-than-expected earnings but provided a cautious outlook. BioVie shares plunged after a secondary offering, while Maison Solutions, Seelos Therapeutics, and Wave Life Sciences saw significant gains. Commodities like oil and silver rose.

Portfolio Pulse from Avi Kapoor

September 24, 2024 | 6:08 pm

SEEL

Seelos Therapeutics (NASDAQ:SEEL) shares surged over 72% after signing a material transfer agreement with the U.S. Army to supply intranasal racemic ketamine (SLS-002) for a PTSD clinical trial. The trial, funded by the Department of Defense, will assess the drug's effectiveness and safety for military personnel and veterans.

Portfolio Pulse from Dylan Berman

September 24, 2024 | 6:06 pm

MULN

Mullen Automotive's stock continues to decline despite updates from CEO David Michery. The company executed a 1-for-100 reverse stock split to comply with Nasdaq's minimum bid price rule, but shares have fallen nearly 50% since. Heavy trading volume is noted.

Portfolio Pulse from Erica Kollmann

September 24, 2024 | 6:01 pm

PPBI

Analysts have mixed views on Pacific Premier Bancorp (NASDAQ:PPBI) with recent ratings showing a shift towards a more neutral stance. The average 12-month price target has increased to $26.5, indicating a slight positive outlook. Despite revenue challenges, the company maintains strong profitability and financial health.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:01 pm

UNH

UnitedHealth Group (UNH) has seen a surge in options activity, with a significant bearish sentiment among investors. The options activity includes 17 puts and 7 calls, indicating a potential price movement between $300 and $660. The stock is currently trading at $572.63, with a slight decrease of 0.14%. Analysts have set an average target price of $591, and Cantor Fitzgerald has downgraded its rating to Overweight.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:01 pm

AMGN

Wealthy investors have shown interest in Amgen (NASDAQ:AMGN) options, with a mix of bullish and bearish trades. Benzinga's options scanner identified 16 unusual trades, indicating potential market movements. The price target for AMGN ranges from $145 to $390, with significant open interest and volume in recent trades.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:01 pm

CBUS

Analysts have varied opinions on Cibus (NASDAQ:CBUS), with recent ratings showing a mix of bullish sentiments. The average 12-month price target is $22.3, slightly down from $22.67. Cibus has shown strong revenue growth but struggles with profitability. Analysts have adjusted their price targets, reflecting evolving market conditions.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:00 pm